Preparation method of ranolazine
The Fmoc-Cl monosubstituted piperazine method simplifies the ranolazine synthesis process, solving the problems of long synthesis routes and numerous by-products in existing technologies, and achieving efficient and low-cost ranolazine production.
Patent Information
- Application Number
- CN202511113290.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-08-11
- Publication Date
- 2025-10-28
- Estimated Expiration
- 2045-08-11
AI Technical Summary
Existing methods for synthesizing ranolazine suffer from drawbacks such as long synthetic routes, numerous byproducts, and significant environmental impact, making it difficult to achieve efficient and low-cost industrial production.
The Fmoc-Cl monosubstituted piperazine method involves reacting N-Fmoc-piperazine with 2-chloro-N-(2,6-dimethyl)acetamide and l-(2-methoxyphenoxy)-2,3-epoxypropane under alkaline conditions, thus avoiding the formation of disubstituted piperazine products, simplifying the process steps, and improving purity and conversion rate.
It effectively reduces the formation of piperazine disubstituted products, lowers raw material costs, improves conversion rate and purity, shortens the production cycle, reduces solvent usage, and is suitable for large-scale production.